Lasam, Elesia T.

HRN: 02-58-85  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/01/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/01/2026
07/08/2026
IV
600mg
Q8
CRBSI
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines